NCT01481883View on ClinicalTrials.gov

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2019

Study Completion Date

February 28, 2019

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Interventions
DRUG

Raloxifene Hydrochloride

120mg daily - 1 capsule daily for 12 week trial

DRUG

Placebo

1 capsule daily for 12 week trial

Trial Locations (1)

3004

Alfred Hospital, Melbourne

All Listed Sponsors
lead

The Alfred

OTHER

NCT01481883 - Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? | Biotech Hunter | Biotech Hunter